DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Neutropenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neutropenia (138)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 138   Next >>

Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-20

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Vincristine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Decadron Phosphate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Velcade
    Dosage: day 1, 4, 8 and 11
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Cytarabine
    Dosage: day 1,8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23

Methotrexate
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

PEG-Asparaginase
    Dosage: day 2, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25
    End date: 2007-10-25

Doxil
    Dosage: day 1
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-08-14

Patient: female, weighing 70.8 kg (155.8 pounds)

Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Cytarabine
    Dosage: 70 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-10-23

Methotrexate Sodium
    Dosage: unk, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2005-01-01
    End date: 2007-01-01

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23

Decadron Phosphate
    Dosage: 9 mg, unk
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2007-10-23
    End date: 2007-10-23



Possible Cytarabine side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-08

Patient: 52 year old male

Reactions: Zygomycosis, Haemoptysis, Neck Pain, Chest Pain, Swelling, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 22.5 mg/m2
    Indication: Acute Myeloid Leukaemia

Idarubicin Hydrochloride
    Dosage: 6 mg/m2, 400 ug, intravenous, every two months
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 0.75 mg/m2
    Indication: Acute Myeloid Leukaemia

Methylprednisolone
    Indication: Acute Myeloid Leukaemia



Possible Cytarabine side effects in 66 year old male

Reported by a physician from France on 2012-08-07

Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Treanda
    Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-27
    End date: 2012-02-28

Melphalan Hydrochloride
    Dosage: 250 mg total dose
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-03-03

Cytarabine
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Etoposide
    Dosage: 400 mg/m2 daily; uid/qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2012-02-28
    End date: 2012-03-02

Treanda
    Indication: non-Hodgkin's Lymphoma



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-08-02

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10

Clofarabine
    Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07

Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-05

Patient: male, weighing 98.5 kg (216.7 pounds)

Reactions: Dyspnoea, Pyrexia, Legionella Infection, Neutropenia, Lobar Pneumonia, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 39600 mg
    End date: 2012-06-10

Daunorubicin HCL
    Dosage: 381 mg
    End date: 2012-03-26



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-02

Patient: male, weighing 98.5 kg (216.7 pounds)

Reactions: Pneumonia, Pyrexia, Neutropenia, Legionella Infection, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from China on 2012-07-02

Patient:

Reactions: Thrombocytosis, NO Therapeutic Response, Febrile Neutropenia, Bone Marrow Failure, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cytarabine
    Dosage: 10 mg/m2, in 1 cyclical
    Indication: Myeloid Leukaemia

Cytarabine
    Dosage: 10 mg/m2, in 1 cyclical
    Indication: Myelodysplastic Syndrome

Decitabine
    Dosage: 15 mg/m2, in 1 cyclical, intravenous
    Indication: Myeloid Leukaemia

Aclarubicin (Aclarubicin) Unspecified
    Dosage: 10 mg, in 1 cyclical
    Indication: Myeloid Leukaemia

Aclarubicin (Aclarubicin) Unspecified
    Dosage: 10 mg, in 1 cyclical
    Indication: Myelodysplastic Syndrome

Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
    Indication: Myelodysplastic Syndrome

Granulocyte Colony Stimulating Factor (Granulocyte Colony Stimulating
    Indication: Myeloid Leukaemia

Other drugs received by patient: Hydroxyurea; Homoharringtonine (Homoharringtonine)



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-06-28

Patient: female, weighing 44.5 kg (97.9 pounds)

Reactions: Hypotension, Pyrexia, Abdominal Pain Upper, Candida Test Positive, Simplex Virus Test Positive, Diarrhoea, Fungal Test Positive, Skin Lesion, Neutropenia, Klebsiella Test Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-L-Asparaginase (K-H)
    Dosage: 3225 unit

Cytarabine
    Dosage: 70 mg

Vincristine Sulfate
    Dosage: 3.88 mg

Methylprednisolone
    Dosage: 813.75 mg

Methotrexate
    Dosage: 15 mg



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-27

Patient:

Reactions: Blood Bilirubin Increased, Vomiting, Nausea, Anaemia, Rash, Fatigue, Aspartate Aminotransferase Increased, Adverse Event, Neutropenia, Rash Maculo-Papular, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Revlimid
    Dosage: 50 milligram
    Administration route: Oral

Revlimid
    Dosage: 10mg-25mg
    Administration route: Oral

Cytarabine
    Dosage: 1.5 milligram/sq. meter

Cytarabine
    Dosage: 10 milligram



Possible Cytarabine side effects in 14 year old male

Reported by a physician from Norway on 2012-06-22

Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Arachnoiditis, Deafness, Pyrexia, Somnolence, Fall, Mucosal Inflammation, Fatigue, C-Reactive Protein Increased, Neutropenia, Sinusitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Celecoxib
    Dosage: 800 milligram
    Administration route: Oral
    Indication: Medulloblastoma

Celecoxib
    Dosage: 100 milligram
    Administration route: Oral

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral

Cytarabine

Cytarabine
    Indication: Medulloblastoma

Etoposide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Medulloblastoma

Etoposide
    Dosage: 12.5 milligram
    Administration route: Oral

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Medulloblastoma

Other drugs received by patient: Prednisolone Succinate; Dexamethasone; Dexamethasone



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from Italy on 2012-06-18

Patient: male

Reactions: Epstein-Barr Virus Infection, Diarrhoea, Anaemia, Sepsis, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Vincristine Sulfate
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Mabthera
    Indication: Burkitt's Lymphoma

Doxorubicin Hydrochloride
    Indication: Burkitt's Lymphoma



Possible Cytarabine side effects in male

Reported by a physician from Italy on 2012-06-14

Patient: male

Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Drug(s) suspected as cause:
Carmustine
    Indication: Burkitt's Lymphoma

Carboplatin
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Melphalan Hydrochloride
    Indication: Burkitt's Lymphoma

Radiotherapy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Unknown Medication
    Dosage: antimicrobial prophylaxis
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication



Possible Cytarabine side effects in 14 year old male

Reported by a physician from Norway on 2012-06-12

Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Arachnoiditis, Deafness, Pyrexia, Fall, Somnolence, Mucosal Inflammation, Fatigue, Neutropenia, Sinusitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Thalidomide
    Dosage: 50 milligram
    Administration route: Oral

Celecoxib
    Dosage: 800 milligram
    Administration route: Oral
    Indication: Medulloblastoma

Cytarabine
    Indication: Medulloblastoma

Etoposide
    Dosage: 12.5 milligram
    Administration route: Oral

Cytarabine

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral
    Indication: Medulloblastoma

Etoposide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Medulloblastoma

Celecoxib
    Dosage: 100 milligram
    Administration route: Oral

Other drugs received by patient: Prednisolone Succinate; Dexamethasone; Dexamethasone



Possible Cytarabine side effects in 17 year old female

Reported by a physician from United States on 2012-06-08

Patient: 17 year old female, weighing 47.6 kg (104.7 pounds)

Reactions: Blood Bilirubin Increased, Pyrexia, Caecitis, Loss of Consciousness, Oedema Peripheral, Pulmonary Oedema, Hypocalcaemia, Acute Respiratory Distress Syndrome, Melaena, Hypertriglyceridaemia, Epistaxis, Dysphagia, Anaemia, Hyperglycaemia, General Physical Health Deterioration, Eating Disorder, Tremor, Cerebral Infarction, Depressed Level of Consciousness, Neutropenia, Confusional State, Dyskinesia, Somnolence, Splenic Infarction, Hypokalaemia, Pleural Effusion, White Blood Cell Count Decreased, Cerebrovascular Accident, Ascites, Diarrhoea, Hypophagia, Hypoalbuminaemia, Sinus Tachycardia, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mercaptopurine
    Dosage: 60mgm2 cyclic
    Administration route: Oral
    Indication: T-Cell Type Acute Leukaemia

Vincristine
    Dosage: 1.5mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Cyclophosphamide
    Dosage: 1000mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Methotrexate
    Indication: T-Cell Type Acute Leukaemia

Oncaspar
    Indication: T-Cell Type Acute Leukaemia

Nelarabine
    Dosage: 650mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia
    Start date: 2012-04-13

Cytarabine
    Dosage: 75mgm2 cyclic
    Indication: T-Cell Type Acute Leukaemia

Dalteparin Sodium
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Nystatin; Lansoprazole; Insulin Aspart; Piperacillin and Tazobactam; Vancomycin; Voriconazole



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-06-05

Patient: female

Reactions: Neutropenia, Device Related Infection, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: itrc
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-23
    End date: 2012-04-23

Dasatinib
    Dosage: 45 milligram;
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-30

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-16
    End date: 2012-04-16

Daunorubicin Hydrochloride
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-16
    End date: 2012-04-30

Dexamethasone
    Dosage: 2/1 day
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-16
    End date: 2012-04-29

Pegaspargase
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-19
    End date: 2012-04-19

Vincristine
    Dosage: 7 day
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-16
    End date: 2012-04-30

Other drugs received by patient: Furosemide; Nystatin; Zantac; Ondansetron



Possible Cytarabine side effects in 38 year old female

Reported by a physician from United States on 2012-06-01

Patient: 38 year old female

Reactions: Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Mesna
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia

Dasatinib
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-04-13



Possible Cytarabine side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 52 year old male

Reactions: Haemoptysis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome Transformation, Local Swelling, Hypokalaemia, Pneumonia Cytomegaloviral, Pulmonary Haemorrhage, Zygomycosis, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clofarabine

Idarubicin HCL

Idarubicin HCL
    Dosage: 6 milligram/sq. meter
    Indication: Myelodysplastic Syndrome

Cytarabine

Vidaza
    Indication: Myelodysplastic Syndrome

Cytarabine
    Dosage: 6 g/m2
    Indication: Myelodysplastic Syndrome

Vidaza

Clofarabine
    Dosage: 22.5 milligram/sq. meter
    Indication: Myelodysplastic Syndrome

Other drugs received by patient: Fluconazole; Ciprofloxacin; Acyclovir; Metformin HCL; Insulin



Possible Cytarabine side effects in

Reported by a individual with unspecified qualification from France on 2012-05-31

Patient:

Reactions: Lung Neoplasm Malignant, Richter's Syndrome, Pancytopenia, Neutropenia, Hodgkin's Disease, Sarcoma Uterus

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Indication: B-Cell Lymphoma

Cisplatin
    Indication: B-Cell Lymphoma

Mabthera
    Indication: B-Cell Lymphoma

Fludarabine Phosphate
    Indication: B-Cell Lymphoma

Oxaliplatin
    Indication: B-Cell Lymphoma

Dexamethasone
    Indication: B-Cell Lymphoma

Cyclophosphamide
    Indication: B-Cell Lymphoma



Possible Cytarabine side effects in female

Reported by a physician from Spain on 2012-05-11

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Bacteraemia, Neutropenia

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Evoltra
    Dosage: 33 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-13
    End date: 2011-04-17

Cytarabine
    Dosage: 33 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-04-13
    End date: 2011-04-26

Other drugs received by patient: Mycostatin; Meropenem; Enalapril Maleate; Metoclopramide; Scopolamine; Acyclovir; Pantoprazole; Chlorhexidine Gluconate; Furosemide



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-05-08

Patient: male, weighing 15.9 kg (35.0 pounds)

Reactions: Cerebral Aspergillosis, Brain Stem Syndrome, Neutropenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Daunorubicin Hydrochloride
    Dosage: 34 mg
    End date: 2012-04-04

Cytarabine
    Dosage: 70 mg
    End date: 2012-03-27

Dexamethasone
    Dosage: 81 mg
    End date: 2012-04-08

Other drugs received by patient: PEG-L Asparaginase (Pegaspargase, Oncospar); Vincristine Sulfate; Methotrexate



Possible Cytarabine side effects in female

Reported by a physician from United Kingdom on 2012-05-03

Patient: female

Reactions: Eye Infection Toxoplasmal, Neutropenia, Uveitis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Etoposide
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Cytarabine
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Everolimus
    Dosage: unk
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Daunorubicin Hydrochloride
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-08-09
    End date: 2011-11-29

Other drugs received by patient: Ondansetron; Codeine; Vancomycin; Bisacodyl; Fluconazole; Docusate Sodium; Citalopram; Citalopram; Cyclizine; Phosphate-Sandoz; Metamucil-2; Zopiclone; Posaconazole; Nilstat; Pyrimethamine TAB; Acyclovir; Slow-K; Granulocyte Colony Stimulating Factor; Sulphadiazine; Scopolamine



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03

Patient:

Reactions: Bronchopulmonary Aspergillosis, Pneumonia Fungal, Respiratory Disorder, Lung Neoplasm, Malignant Lymphoma Unclassifiable High Grade, Neutropenia, Immunosuppression

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Carmustine
    Indication: Chronic Lymphocytic Leukaemia

Etoposide
    Indication: Chronic Lymphocytic Leukaemia

(Rituximab)
    Indication: Chronic Lymphocytic Leukaemia

(Chlorambucil)
    Indication: Chronic Lymphocytic Leukaemia

Prednisolone
    Indication: Chronic Lymphocytic Leukaemia

Fludarabine Phosphate
    Indication: Chronic Lymphocytic Leukaemia

Melphalan Hydrochloride
    Indication: Chronic Lymphocytic Leukaemia

Cytarabine
    Indication: Chronic Lymphocytic Leukaemia



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03

Patient:

Reactions: Bronchopulmonary Aspergillosis, Pneumonia Fungal, Respiratory Disorder, Lung Neoplasm, Chronic Lymphocytic Leukaemia Transformation, Malignant Lymphoma Unclassifiable High Grade, Neutropenia, Immunosuppression

Adverse event resulted in: death

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Cytarabine
    Indication: Chronic Lymphocytic Leukaemia

Carmustine
    Indication: Chronic Lymphocytic Leukaemia

Fludarabine Phosphate
    Indication: Chronic Lymphocytic Leukaemia

(Rituximab)
    Indication: Chronic Lymphocytic Leukaemia

Prednisolone
    Indication: Chronic Lymphocytic Leukaemia

Etoposide
    Indication: Chronic Lymphocytic Leukaemia

(Chlorambucil)
    Indication: Chronic Lymphocytic Leukaemia



Possible Cytarabine side effects in

Reported by a physician from United States on 2012-04-27

Patient:

Reactions: Pancytopenia, Febrile Neutropenia, Mantle Cell Lymphoma, Disease Progression, Mucosal Inflammation, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Tositumomab-Iodine 131
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Mantle Cell Lymphoma

Tositumomab-Iodine 131
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Rituximab
    Indication: Mantle Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Cytarabine
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma



Possible Cytarabine side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-24

Patient:

Reactions: Pancytopenia, Febrile Neutropenia, Mantle Cell Lymphoma, Disease Progression, Mucosal Inflammation, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Diffuse Large B-Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Mantle Cell Lymphoma

Etoposide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Diffuse Large B-Cell Lymphoma

Tositumomab-Iodine 131
    Indication: Mantle Cell Lymphoma

Rituximab
    Indication: Diffuse Large B-Cell Lymphoma

Etoposide
    Indication: Diffuse Large B-Cell Lymphoma

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma

Rituximab
    Indication: Mantle Cell Lymphoma

Tositumomab-Iodine 131
    Indication: Diffuse Large B-Cell Lymphoma



Possible Cytarabine side effects in 14 year old male

Reported by a individual with unspecified qualification from Norway on 2012-04-23

Patient: 14 year old male

Reactions: Stomatitis, Ataxia, Febrile Neutropenia, Cognitive Disorder, Dysarthria, Neurotoxicity, Fatigue, Visual Impairment, Hypothyroidism, Coordination Abnormal, Neutropenia, Sinusitis

Drug(s) suspected as cause:
Temozolomide
    Indication: Medulloblastoma

Exitop Kapsler 100 MG
    Indication: Medulloblastoma

Lomustine
    Indication: Medulloblastoma

Cisplatin
    Indication: Medulloblastoma

Carboplatin
    Indication: Medulloblastoma

Sendoxan 1000 MG Pulver TIL Injeksjonsv?ske, Oppl?sning
    Indication: Medulloblastoma

Celecoxib
    Administration route: Oral
    Indication: Medulloblastoma

Cytarabine
    Indication: Medulloblastoma

Vincristine Sulfate
    Indication: Medulloblastoma

Thalidomide
    Administration route: Oral
    Indication: Medulloblastoma



Possible Cytarabine side effects in

Reported by a physician from United States on 2012-04-12

Patient:

Reactions: Nausea, Haemorrhage, Pain, Rash, Pyrexia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Revlimid
    Dosage: 5mg escalated in 5mg increments to 25mg/day max
    Administration route: Oral

Cytarabine
    Dosage: 100 milligram/sq. meter

Idarubicin HCL
    Dosage: 12 milligram/sq. meter



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-04-11

Patient: female, weighing 19.1 kg (42.0 pounds)

Reactions: Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 24 mg

PEG-L-Asparaginase (Pegaspargase, Oncospar)
    Dosage: 1750 iu

Cytarabine
    Dosage: 70 mg

Vincristine Sulfate
    Dosage: 4.2 mg

Dexamethasone
    Dosage: 108 mg

Other drugs received by patient: Ranitidine; Mirilax; Trimethoprim + Sulfamethoxazole; Lactulose; Acetaminaphen-Codeine; Gabapentin



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-04-11

Patient: female, weighing 65.8 kg (144.8 pounds)

Reactions: Pneumonia, Pseudomonal Sepsis, Neutropenia, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 5-25mg
    Administration route: Oral

Idarubicin HCL
    Dosage: 12 milligram/sq. meter

Cytarabine
    Dosage: 100 milligram/sq. meter

Revlimid
    Dosage: 20 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-08-30

Other drugs received by patient: Metoprolol Tartrate; Bumex; Filgrastim; Acyclovir; Allopurinol; Bumex; Docusate; Lunesta; Tylenol (Caplet); Loperamide; Albumin (Human); FAT Emulsion; Loratadine; Magnesium Oxide; Metoprolol Tartrate; Clarinex; Hydrocortisone; Regular Insulin; Dextrose; Piperacillin and Tazobactam; Potassium Chloride; Fluticasone Furoate; Nexium; TPN; Hydroxyzine; Simethicone; Simethicone; Vesicare; Pantoprazole



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014